Results
1 -
10 of
119Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain, Advances in Therapy Clinical trials report, Current Infectious Disease Reports The Role of Second-Generation Antifungal Triazoles for Treatment of the Endemic Mycoses, Current Infectious Disease Reports Invasive opportunistic mycoses: Clinical trials review, 2007u20132008, Current Infectious Disease Reports Current Controversies in the Treatment of Fungal Infections, Principles and Practice of Cancer Infectious Diseases Fungal Drug Resistance and Pharmacologic Considerations of Dosing Newer Antifungal Therapies, Principles and Practice of Cancer Infectious Diseases Arzneimittel-Interaktionen mit systemischen Antimykotika beim Intensivpatienten, Intensivmedizin und Notfallmedizin Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation, The European Journal of Health Economics Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands, Annals of Hematology